Financial Daily from THE HINDU group of publications
Friday, Dec 03, 2004

Cross Currency

Group Sites

Industry & Economy - Health

Doors not closed for dropped anti-AIDS drugs, says WHO

Our Bureau

New Delhi , Dec. 2

THE World Health Organisation (WHO) will consider re-listing the dropped anti-AIDS or anti-retroviral drugs manufactured by Indian generic companies if they comply with the international requirements and standards.

"We have full faith in the capability of Indian manufacturers to produce quality drugs, but they need to comply with good clinical and laboratory practices," said Ms Joy Phumaphi, Assistant Director General (Family and Community Health), WHO.

A few months ago, the WHO had dropped two drugs manufactured by Cipla and three by Ranbaxy from its pre-qualification list. Just a couple of days ago, it reinstated two drugs from the Cipla stable. The remaining three drugs made by Ranbaxy would be enlisted the moment they fulfil the specifications prescribed by the WHO, she said.

Meanwhile, the UN organisation also warned India not to be complacent in its fight against HIV/AIDS. Though the country has been successful in stabilising the situation regarding the spread of the killer disease, it is far from conquering it, she added.

"Today woman was the face of AIDS, whether as infected or as affected. When infected with AIDS, she gets the least support and medical care, and when living with the infected, it is she who has to nurse and give all type of support to the victim," said Ms Phumaphi.

She further added that the economic situation in India has also contributed to the spread of AIDS as there is large-scale movement of workers from one city to another.

More Stories on : Health | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
NSB Helpline for job candidates

Monsoon lean patch in Kerala
TN: CM to inaugurate wind turbine generator
Kerala CM's offer on Budget session
Kerala: Finance Dept needs to assert itself on spending proposals, says expert
Plan outlay for Tripura pegged at Rs 804 cr
Rs 685-crore Plan outlay for Mizoram
China-India trade touches $10 b in nine months
India Inc makes inroads into Africa — Auto majors, pharma cos join the fray
Indo-LAC meet generates enquiries worth $15m
Tatarstan team in Hyderabad
Doors not closed for dropped anti-AIDS drugs, says WHO
Dentists group bid to make treatment costs affordable
Kerala State Textiles Corp H1 operating profit at Rs 49.61 lakh
Asian oil producers to meet consumer nations on Jan 6
Govt scrutiny of new drugs to be more stringent
Will SAFTA boost pharma trade with Pakistan?
Steel regulator on the anvil: Paswan
Horizontal fiscal imbalances — Equity and efficacy options for transfers
98,000 service providers register under self-declaration scheme
VAT regime — Input tax on goods sold via inter-State trade refundable
Labour issues, slow investment pace — Meeting $50-b textiles export target `difficult'
Financing schemes for SMEs
ONGC, CIL tie-up for coal gasification projects hits a snag
Coal blocks allotted to Videocon, Lloyds Metal, Kalinga cancelled
Performance-linked promotions for teaching staff mooted
`Engg colleges short of students; on verge of closure'
Legislation for varsity status
`Left-hand drive vehicles can be imported for R&D'
Brisk business
Spot gold may test resistance level
Focus on topical technology, Sibal urges Indo-US forum
Union Minister visits NFC
`Disabled need more jobs, not concessions'
Get set for land distribution on Jan 26, AP CM tells Collectors
Chidambaram to inaugurate India Economic Summit
Rs 50-lakh biz at Print expo
In Hyderabad today
Corporate quiz in Hyderabad
Rubber exporters fret over cut in quantity for subsidy
Spices Board hikes airfreight subsidy for cardamom exports
India, Brazil top list of price competitive tourism destinations
Swiss Tourism to hold roadshows from Dec 8-16
Anti-corruption campaign by Lok Satta

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line